450 related articles for article (PubMed ID: 19948204)
1. Factors to consider in the use of stem cells for pharmaceutic drug development and for chemical safety assessment.
Trosko JE; Chang CC
Toxicology; 2010 Mar; 270(1):18-34. PubMed ID: 19948204
[TBL] [Abstract][Full Text] [Related]
2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
3. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy'': stem cells and cell-cell communication as fundamental targets in assessing the potential toxicity of chemicals.
Trosko JE
Hum Exp Toxicol; 2010 Jan; 29(1):21-9. PubMed ID: 20061464
[TBL] [Abstract][Full Text] [Related]
4. Stem cells in toxicology: fundamental biology and practical considerations.
Kang KS; Trosko JE
Toxicol Sci; 2011 Mar; 120 Suppl 1():S269-89. PubMed ID: 21163910
[TBL] [Abstract][Full Text] [Related]
5. A paradigm shift is required for the risk assessment of potential human health after exposure to low level chemical exposures: a response to the toxicity testing in the 21st century report.
Trosko JE; Upham BL
Int J Toxicol; 2010 Jul; 29(4):344-57. PubMed ID: 20634539
[TBL] [Abstract][Full Text] [Related]
6. Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate.
Int J Toxicol; 2007; 26 Suppl 3():1-30. PubMed ID: 18273450
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
Romano G
Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
[TBL] [Abstract][Full Text] [Related]
9. Endless possibilities: stem cells and the vision for toxicology testing in the 21st century.
Chapin RE; Stedman DB
Toxicol Sci; 2009 Nov; 112(1):17-22. PubMed ID: 19703945
[TBL] [Abstract][Full Text] [Related]
10. Embryonic stem cell test: stem cell use in predicting developmental cardiotoxicity and osteotoxicity.
Kuske B; Pulyanina PY; zur Nieden NI
Methods Mol Biol; 2012; 889():147-79. PubMed ID: 22669664
[TBL] [Abstract][Full Text] [Related]
11. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
Brent RL
Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
[TBL] [Abstract][Full Text] [Related]
12. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
Prestwich GD
Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
[TBL] [Abstract][Full Text] [Related]
13. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
14. Challenges of using pluripotent stem cells for safety assessments of substances.
Vojnits K; Bremer S
Toxicology; 2010 Mar; 270(1):10-7. PubMed ID: 20004228
[TBL] [Abstract][Full Text] [Related]
15. Human embryonic stem cell technologies and drug discovery.
Jensen J; Hyllner J; Björquist P
J Cell Physiol; 2009 Jun; 219(3):513-9. PubMed ID: 19277978
[TBL] [Abstract][Full Text] [Related]
16. Small molecules for stem cells.
Kochegarov A
Expert Opin Ther Pat; 2009 Mar; 19(3):275-81. PubMed ID: 19441903
[TBL] [Abstract][Full Text] [Related]
17. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).
Brent RL
Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191
[TBL] [Abstract][Full Text] [Related]
18. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
19. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming.
Li W; Ding S
Trends Pharmacol Sci; 2010 Jan; 31(1):36-45. PubMed ID: 19896224
[TBL] [Abstract][Full Text] [Related]
20. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
